-
Mutual Funds
-
Insurance
-
Calculators
Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
Compare Mutual Funds
Comparing Tata India Pharma & HealthCare Fund vs SBI Healthcare Opportunities FundComparing 2/4 funds
- Add Fund
- Add Fund
- Category,
Sub-category - equity, sectoral-pharma
- equity, sectoral-pharma
- Fund Age
- 9 yrs 7 m
- 12 yrs 6 m
- Fund Size
- ₹1,232 Cr
- ₹3,671 Cr
- 3 months
- 12.64%
- 13.17%
- 6 months
- -2.55%
- 0.59%
- 1 year
- 12.83%
- 20.95%
- 3 year
- 25.33%
- 31.0%
- 5 year
- 22.39%
- 26.13%
- Standard Deviation
- 15.93
- 13.71
- Sharpe
- 1.1
- 1.58
- Beta
- 0.98
- 0.84
- Sortino
- 1.69
- 2.27
- Alpha
- -1.86
- 5.19
- Top 3 sectors
- Healthcare (87.23000000000002%)
- Services (2.19%)
- Chemicals (1.4100000000000001%)
- Healthcare (93.26%)
- Chemicals (2.83%)
- Top 5 holdings
- Sun Pharmaceutical Industries Ltd. (11.64%)
- Apollo Hospitals Enterprise Ltd. (6.22%)
- Cipla Ltd. (5.83%)
- Aurobindo Pharma Ltd. (5.73%)
- Divi's Laboratories Ltd. (5.63%)
- Sun Pharmaceutical Industries Ltd. (12.73%)
- Divi's Laboratories Ltd. (7.39%)
- Max Healthcare Institute Ltd. (6.4%)
- Lonza Group Ag (4.81%)
- Cipla Ltd. (4.77%)
- Equity%
- 90.83%
- 97.41%
- Debt%
- 0.0%
- 0.08%
- Turnover Ratio
- NA
- NA
- Yield To Maturity
- NA
- NA
- Modified Duration
- NA
- NA
- Avg. Maturity
- NA
- NA
- Avg. Credit Quality
- NA
- NA
- Expense Ratio
- 2.12%
- 0.9%
- Exit Load
- 0.25% know more
- 0.5% know more
- Lock-in
- No Lockin
- No Lockin
- Benchmark Index
- NIFTY Pharma TRI
- BSE Healthcare TRI
- Min. Investment
- SIP ₹500 & Lumpsum ₹5000
- SIP ₹500 & Lumpsum ₹5000
- Investment Horizon
- Good for Long Term
- Good for Long Term
- Managed By
- Meeta Shetty
- Rajat Srivastava
- Tanmaya Desai
